Cellectar Biosciences (CLRB) Financials: Revenue & Earnings

CLRB price $1.24 +0.03 +2.48%

Ticker
CLRB
Price
$1.24
Change
+0.03 +2.48%
Market cap ?
$11.72M
P/E ?
-0.27
Forward P/E ?
1.55
Dividend yield ?
0.00%
Beta ?
0.58
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
0000000000

Cellectar Biosciences is a biopharmaceutical firm engaged in the research, development, and market introduction of therapeutic agents to combat cancer. The company's primary asset is CLR 131 (iopofosine I-131), a phospholipid drug conjugate (PDC), which is currently undergoing several clinical evaluations. It is in Phase 2 clinical trials for individuals with relapsed or refractory (r/r) Waldenstrom's…

Fair value

CLRB fair value $30.96. Price $1.24. Price is 96% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare CLRB

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.56—17.00M
2026-08-13-0.57-0.52—12.00M
2026-05-14-1.33-1.89—8.00M
2026-03-04-0.53-1.19—12.77M
2025-11-13-1.41-1.91——
2025-08-14-3.39-3.60——
2025-05-13-3.90-5.11——
2025-03-13-0.01-0.38——
2024-11-18-16.52-0.35——
2024-08-13-5.40-0.23——
2024-05-14-12.01-15.02——
2024-03-27-19.82-1.00——
2023-11-13-24.62-13.21——
2023-08-14-0.73-0.69——
2023-05-04-0.76-0.75——
2023-03-09-0.55-0.83——
2022-11-03-1.28-1.21——
2022-08-05-1.22-1.08——
2022-05-10-1.00-1.10——
2022-03-21-1.00-1.00——
2021-11-08-1.00-1.10——
2021-08-09-1.10-1.10——
2021-05-10-1.30-0.90——
2021-03-02-0.70-1.50——
2020-11-09-1.50-1.50——
2020-08-10-2.60-3.00——
2020-05-07-4.20-3.40——
2020-03-09-3.30-3.60——
2019-11-12-4.20-3.80——
2019-08-12-4.60-6.00——
2019-05-06-7.60-5.00——
2019-02-26-6.20-10.00——
2018-11-13-16.50-8.30——
2018-08-10-16.90-21.00——
2018-05-11-21.00-20.00——
2018-03-21-3,400.00-23.00——
2017-11-09-26.00-25.00——
2017-08-14-23.00-24.00——
2017-05-11-24.00-23.00——
2017-03-15-35.00-23.00——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-08Loren StefanBuy15.00K$2.6940.35K
2026-07-08Loren StefanBuy15.00K$2.6840.20K
2026-07-07Kolean Chad JBuy92.00K$3.14288.88K
2026-07-07DRISCOLL FREDERICK WBuy25.00K$2.7067.50K
2026-07-07Chanan-Khan AsherBuy25.00K$2.7067.50K
2026-07-07CARUSO JAMES VBuy250.00K$3.14785.00K
2026-07-07Gu AndrewBuy25.00K$2.7067.50K
2026-07-07Longcor JarrodBuy118.00K$3.14370.52K
2026-07-07Swirsky Douglas JBuy37.50K$2.70101.25K
2026-07-07NEIS JOHNBuy25.00K$2.7067.50K
2026-05-18Gu AndrewOther0——
2026-05-07Longcor JarrodBuy26.04K$2.8875.00K
2026-05-07Longcor JarrodBuy8.68K$2.8825.00K
2026-05-07CARUSO JAMES VBuy26.04K$2.8875.00K
2026-05-07CARUSO JAMES VBuy8.68K$2.8825.00K
2025-12-12NEIS JOHNSell198$3.70732
2025-07-02CARUSO JAMES VBuy10.00K$4.9949.90K
2025-07-02CARUSO JAMES VBuy10.00K$5.2552.50K
2025-07-02Longcor JarrodBuy10.00K$4.9949.90K
2025-07-02Longcor JarrodBuy10.00K$5.2552.50K
2025-07-02Kolean Chad JBuy5.00K$4.9924.95K
2025-07-02Kolean Chad JBuy5.00K$5.2526.25K
2025-02-14Swirsky Douglas JBuy90.00K$0.2926.10K
2025-02-14NEIS JOHNBuy60.00K$0.2917.40K
2025-02-14Loren StefanBuy60.00K$0.2917.40K
2025-02-14Longcor JarrodBuy500.00K$0.29145.00K
2025-02-14Kolean Chad JBuy290.00K$0.2984.10K
2025-02-14DRISCOLL FREDERICK WBuy60.00K$0.2917.40K
2025-02-14Chanan-Khan AsherBuy60.00K$0.2917.40K
2025-02-14CARUSO JAMES VBuy900.00K$0.29261.00K
2025-01-10Longcor JarrodBuy30.00K$0.288.40K
2024-06-14Longcor JarrodBuy500.00K$2.651.32M
2024-06-14CARUSO JAMES VBuy900.00K$2.652.38M
2024-06-14Kolean Chad JBuy290.00K$2.65768.50K
2024-06-14Shustov AndreiBuy260.00K$2.65689.00K
2024-06-14Lea Darrell ShaneBuy260.00K$2.65689.00K
2024-06-14Loren StefanBuy60.00K$2.58154.80K
2024-06-14Swirsky Douglas JBuy90.00K$2.58232.20K
2024-06-14NEIS JOHNBuy60.00K$2.58154.80K
2024-06-14DRISCOLL FREDERICK WBuy60.00K$2.58154.80K
2024-06-14Chanan-Khan AsherBuy60.00K$2.58154.80K
2023-12-08Lea Darrell ShaneBuy39.60K——
2023-12-08Kolean Chad JBuy42.55K——
2023-12-08Shustov AndreiBuy47.86K——
2023-12-08Longcor JarrodBuy42.93K——
2023-12-08CARUSO JAMES VBuy40.60K——
2023-06-28Swirsky Douglas JBuy37.50K$1.8569.38K
2023-06-28NEIS JOHNBuy25.00K$1.8546.25K
2023-06-28Loren StefanBuy25.00K$1.8546.25K
2023-06-28DRISCOLL FREDERICK WBuy25.00K$1.8546.25K
2023-06-28Chanan-Khan AsherBuy25.00K$1.8546.25K
2023-06-23Lea Darrell ShaneBuy100.00K$1.68168.00K
2023-06-23Kolean Chad JBuy104.00K$1.68174.72K
2023-06-23Longcor JarrodBuy144.00K$1.68241.92K
2023-06-23CARUSO JAMES VBuy261.00K$1.68438.48K
2023-02-15Shustov AndreiBuy100.00K$1.67167.00K
2023-02-15Shustov AndreiSell0——
2023-01-17Longcor JarrodBuy144.00K——
2023-01-17CARUSO JAMES VBuy261.00K——
2023-01-17Kolean Chad JBuy104.00K——
2022-11-21Lea Darrell ShaneBuy100.00K——
2022-11-21Lea Darrell ShaneOther———
2022-11-21Lea Darrell ShaneOther0——
2022-06-24Swirsky Douglas JBuy11.70K——
2022-06-24Swirsky Douglas JBuy11.70K$4.1047.97K
2022-06-24NEIS JOHNBuy7.80K——
2022-06-24Loren StefanBuy7.80K——
2022-06-24Loren StefanBuy7.80K$4.1031.98K
2022-06-24DRISCOLL FREDERICK WBuy7.80K——
2022-06-24Chanan-Khan AsherBuy7.80K——
2022-02-24Kolean Chad JSell0——
2022-02-22Kolean Chad JBuy150.00K$0.4973.50K
2022-02-22Kolean Chad JOther0——
2022-01-25Longcor JarrodBuy475.00K$0.55261.25K
2022-01-25Elefant DovBuy422.00K$0.55232.10K
2022-01-25CARUSO JAMES VBuy1.42M$0.55780.45K
2021-09-14Swirsky Douglas JBuy25.00K$1.0426.00K
2021-09-03DRISCOLL FREDERICK WBuy19.42K$1.0420.24K
2021-06-30Swirsky Douglas JBuy117.00K$1.19139.23K
2021-06-30Loren StefanBuy78.00K$1.1992.82K
2021-06-30NEIS JOHNBuy78.00K$1.1992.82K
2021-06-30DRISCOLL FREDERICK WBuy78.00K$1.1992.82K
2021-06-30Chanan-Khan AsherBuy78.00K$1.1992.82K
2021-06-23Chanan-Khan AsherOther0——
2021-03-18NEIS JOHNSell23.23K$30.40706.25K
2021-03-17NEIS JOHNSell58.64K$30.401.78M
2021-03-16NEIS JOHNSell100.52K$30.403.06M
2021-03-15NEIS JOHNSell11.20K$30.40340.48K
2021-03-12NEIS JOHNSell41.16K$30.401.25M
2021-03-04Elefant DovBuy430.00K$1.74748.20K
2021-03-04Longcor JarrodBuy450.00K$1.74783.00K
2021-03-04Friend John E. IIBuy330.00K$1.74574.20K
2021-03-04CARUSO JAMES VBuy1.60M$1.742.78M
2021-03-04CARUSO JAMES VBuy5.10K$1.708.66K
2021-03-04CARUSO JAMES VBuy46.95K$30.401.43M
2020-12-28CARUSO JAMES VBuy37.04K$1.3550.00K
2020-12-28Longcor JarrodBuy29.63K$1.3540.00K
2020-12-28Elefant DovBuy7.41K$1.3510.00K
2020-07-01Friend John E. IIBuy100.00K$1.34134.00K
2020-07-01Friend John E. IISell0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 29, holders +10 vs prior quarter. Ownership 26.65%.

HolderSharesChangeChange %Value
CALIGAN PARTNERS LP470.00K470.00KNew1.31M
STEMPOINT CAPITAL LP354.94K354.94KNew986.73K
VANGUARD CAPITAL MANAGEMENT LLC327.37K245.48K+299.79%910.08K
SILVERARC CAPITAL MANAGEMENT, LLC321.73K321.73KNew894.40K
BLEICHROEDER LP288.68K188.68K+188.68%802.53K
JUPITER TOPCO LLC274.16K274.16KNew759.41K
BALYASNY ASSET MANAGEMENT L.P.220.00K220.00KNew611.60K
NANTAHALA CAPITAL MANAGEMENT, LLC220.00K220.00KNew611.59K
EMPERY ASSET MANAGEMENT, LP189.60K189.60KNew527.10K
DIADEMA PARTNERS LP138.34K138.34KNew384.59K
STONEPINE CAPITAL MANAGEMENT, LLC104.55K104.55KNew290.65K
PERSISTENT ASSET PARTNERS LTD92.98K92.98KNew258.49K
BOOTHBAY FUND MANAGEMENT, LLC85.07K85.07KNew236.49K
GEODE CAPITAL MANAGEMENT, LLC53.35K573+1.09%148.32K
VANGUARD FIDUCIARY TRUST CO46.22K29.65K+178.89%128.49K
SEQUOIA FINANCIAL ADVISORS, LLC21.85K3.00K+15.92%60.74K
RIVERVIEW CAPITAL ADVISERS, LLC10.38K00.00%50.05K
ACADIAN ASSET MANAGEMENT LLC16.58K16.58KNew46.00K
NORTHERN TRUST CORP14.84K14.84KNew41.25K
BLACKROCK, INC.4.74K-10-0.21%13.16K
UBS GROUP AG3.09K-6.55K-67.94%8.60K
BARCLAYS PLC561561New1.56K
MORGAN STANLEY51000.00%1.42K
TD WATERHOUSE CANADA INC.6300.00%178
SBI SECURITIES CO., LTD.1100.00%31

Earnings and financials

Cellectar Biosciences, Inc. (CLRB) trades at $1.24, with a market cap of $11.72M and a trailing P/E of -0.27. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
0000000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Cellectar Biosciences (CLRB) Financials: Revenue & Earnings

CLRB$1.24+0.03 +2.48%

$11.72M

Market Cap

-0.27

P/E

1.55

Forward P/E

—

Score

Price History